Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To isolate a plant-derived compound with efflux inhibitory activity towards the NorA transporter of Staphylococcus aureus. METHODS: Bioassay-guided isolation was used, with inhibition of ethidium bromide efflux via NorA as a guide. Characterization of activity was carried out using MIC determination and potentiation studies of a fluoroquinolone antibiotic in combination with the isolated compound. Everted membrane vesicles of Escherichia coli cells enriched with NorA were prepared to study efflux inhibitory activity in an isolated manner. RESULTS: The ethanolic extract of Persea lingue was subjected to bioassay-guided fractionation and led to the isolation of the known compound kaempferol-3-O-α-L-(2,4-bis-E-p-coumaroyl)rhamnoside (compound 1). Evaluation of the dose-response relationship of compound 1 showed that ethidium bromide efflux was inhibited, with an IC(50) value of 2 μM. The positive control, reserpine, was found to have an IC(50) value of 9 μM. Compound 1 also inhibited NorA in enriched everted membrane vesicles of E. coli. Potentiation studies revealed that compound 1 at 1.56 mg/L synergistically increased the antimicrobial activity of ciprofloxacin 8-fold against a NorA overexpresser, and the synergistic activity was exerted at a fourth of the concentration necessary for reserpine. Compound 1 was not found to exert a synergistic effect on ciprofloxacin against a norA deletion mutant. The 2,3-coumaroyl isomer of compound 1 has been shown previously not to cause acute toxicity in mice at 20 mg/kg/day. CONCLUSIONS: Our results show that compound 1 acts through inhibition of the NorA efflux pump. Combination of compound 1 with subinhibitory concentrations of ciprofloxacin renders a wild-type more susceptible and a NorA overexpresser S. aureus susceptible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Stermitz, F. R., Scriven, L. N., Tegos, G., & Lewis, K. (2002) · Planta Medica · doi:10.1055/s-2002-36347 · Cited by 114
Cited by
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants
Blanco, P., Hernando-Amado, S., Reales-Calderon, J., Corona, F., Lira, F., Alcalde-Rico, M., Bernardini, A., Sanchez, M., & Martinez, J. (2016) · Microorganisms · doi:10.3390/microorganisms4010014 · Cited by 663
Plant-Derived Antimicrobial Compounds: Alternatives to Antibiotics
Savoia, D. (2012) · Future Microbiology · doi:10.2217/fmb.12.68 · Cited by 601
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Efflux pump inhibitors for bacterial pathogens: From bench to bedside
Sharma, A., Gupta, V. K., & Pathania, R. (2019) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2079_17 · Cited by 458
Development of botanicals to combat antibiotic resistance
Gupta, P. D., & Birdi, T. J. (2017) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.05.004 · Cited by 371
Ayaz, M., Ullah, F., Sadiq, A., Ullah, F., Ovais, M., Ahmed, J., & Devkota, H. P. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.050 · Cited by 359
Linking Jasmonic Acid Signaling, Root Exudates, and Rhizosphere Microbiomes
Carvalhais, L. C., Dennis, P. G., Badri, D. V., Kidd, B. N., Vivanco, J. M., & Schenk, P. M. (2015) · Molecular Plant-Microbe Interactions® · doi:10.1094/mpmi-01-15-0016-r · Cited by 312
AlSheikh, H. M. A., Sultan, I., Kumar, V., Rather, I. A., Al-Sheikh, H., Tasleem Jan, A., & Haq, Q. M. R. (2020) · Antibiotics · doi:10.3390/antibiotics9080480 · Cited by 295
Exploring phytochemicals for combating antibiotic resistance in microbial pathogens
Khare, T., Anand, U., Dey, A., Assaraf, Y. G., Chen, Z.-S., Liu, Z., & Kumar, V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720726 · Cited by 281
“Kaempferol (flavonoid) and its natural glycoside derivative from Persea lingue proved to increase the antimicrobial potential of ciprofloxacin in a NorA overexpressed S. aureus strain (Holler et al., 2012).”
BackgroundThe intrinsic resistome of bacterial pathogens
Olivares, J., Bernardini, A., Garcia-Leon, G., Corona, F., B. Sanchez, M., & Martinez, J. L. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00103 · Cited by 177
“…a variety of EPIs (Tegos et al., 2002; Musumeci et al., 2003; Lewis and Ausubel, 2006; Stavri et al., 2007), which may be useful for increasing the susceptibility to antibiotics of different bacterial species (Groblacher et al., 2012a,b; Holler et al., 2012a; Roy et al., 2012; Zhou et al., 2012).”
BackgroundAndersen, J., He, G.-X., Kakarla, P., KC, R., Kumar, S., Lakra, W., Mukherjee, M., Ranaweera, I., Shrestha, U., Tran, T., et al. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120201487 · Cited by 167
“Other inhibitors of the NorA efflux pump includes chalcone [127], capsaicin [128], kaempferol rhamnoside [129], ofloxacin based efflux pump inhibitors [130], thiopyranopyridine moiety [131], omeprazole derivatives [132], flavones, isoflavones, neohesperidosides, pentaester, spinosan A, pterocarpan, orizabin XIX, oriza…”
Background
Metadata
- Authors
- Holler, J. G., Christensen, S. B., Slotved, H.-C., Rasmussen, H. B., Guzman, A., Olsen, C.-E., Petersen, B., & Molgaard, P.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-06
- Volume
- 67
- Issue
- 5
- Pages
- 1138-1144
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2121248092
- Cited by
- 151
- References
- 2
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.